An announcement from Citius Oncology ( ($CTOR) ) is now available. On December 1, 2025, Citius Oncology announced the commercial launch of ...
Stocktwits on MSN
Citius Oncology Launches Lymphir In US For Skin Cancer
Citius Oncology (CTOR) said on Monday it has launched Lymphir, a newly approved cancer immunotherapy for adults with relapsed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback